The Pfizer and the Moderna vaccines are in the market, and the clinical trials have already begun showing amazing results. But, the dilemma is that of the rollout of the vaccine.Does the governments of nations have the potential for quick distribution of the vaccine?
A recent account in devex shows that AI development can help the COVID 19 vaccine reach nearly 80 percent of the global population who currently live in low and middle-income countries, which is almost 2 billion people.
Pfizer and Moderna leveraged cutting-edge science to develop the vaccine, and it seems that it is again the technology that will go parallelly until the vaccine shots are given to every needy.
We human beings cannot take thousands of competing and evolving factors into consideration, and this is where AI comes into play. Since the beginning of the COVID19 pandemic, AI and other digital tools have crunched thousands of scientific papers to develop the vaccine. This time, AI is there to process the data much faster than humans can and speed up the vaccine roll out and tracking.
This post will see how pharmaceutical companies can use AI approaches, recommendations, and strategies to make a difference in the vaccine rollout. Before this, let’s have a look at the four distinct areas in which AI plays a major role.
• Triage and impact modeling
The AI technology helps figure out the needy from the population group who quickly needs to be vaccinated to end the COVID 19 pandemic.
• Demand forecastin
It determines the areas where the vaccine needs to be shipped and when they need it. This will help the needy masses to be vaccinated in the least amount of time.
• Supply chain management
Monitors the production of the doses and delivery network to avoid bottlenecks in supply chain management.
• Post-vaccination supervision
There might be some post adverse side effects from the trial; AI watches out for those signs and informs the relevant authorities about them.
Pharmaceuticals giant exploring the role of AI in the vaccine rollout.
Genpact, UK
With the help of Genpact A, the UK government can track events by batch, lot, and location much easier than humans can do. AI can track issues such as ethnicity, gender, age, and other demographic factors that can affect doses.
“AI can handle thousands of dimensions of data and find patterns and signals in the data very rapidly, something that would take humans much longer to find.”
Pharmaceutical companies are exploring AI’s role in the availability, procurement, tracing, delivery logistics, and storage of the vaccine in supply chain management.
Now let talk about the main benefits of AI in Covid 19 vaccine rollout & tracking:
1. Figures out the reaction of the population
After the COVID 19 vaccine rollout among the population worldwide, AI will help us see the entire scene and the possible adverse effects caused by it. It will provide insights into the patients’ reactions after the vaccination based on their demographic information and medical history.
2. Vaccine reporting process
AI informs about the vaccine reporting process because this process has multiple steps for accurate reporting of data. It allows for less inspection by humans and sinks the data onto one plane. This prevents the healthcare institutions from building reports for multiple EHR (Electronic Health Records) or pharmacy systems.
3. Ensures continuous supply
AI systems ensure a continuous supply to avoid complexity in the supply chain. It allows for real-time visibility of the supply chain performance and provides autonomous supply operations to allocate materials and distribute products.
4. RPA bot well-positioned to now help track flu vaccinations in the UK
The NHS is now reviewing plans to extend the technology to report on COVID-19 vaccinations, recently approved to be administered in the UK. NHS Foundation Trust in the UK uses the AI tool to track the COVID 19 vaccine rollout, which has been earlier deployed to track flu vaccinations in the UK.
The flu-reporting bot is making use of the AI tool to improve data accuracy and ensures that the valuable time is not diverted from supporting staff and patient care.”
5. AI communicates well
Artificial Intelligence targets messages and helps in connecting with needy citizens. AI customizes the message’s content that motivates the citizens to take the vaccine by looking at the profession and vulnerability of the masses.
The technology personalizes the messages that help citizens access the vaccine either by phone call, website, or text.
6. AI helps in healthy decision-makin
Healthcare workers often see the COVID 19 vaccine’s distribution process on a macro-level, but the scene is quite different. We need to analyze it on a smaller scale because we can better allocate the vaccines within a state, locations, and subpopulations.
AI-augmented simulations help roll out the vaccine in a dozen locations within a state by considering several factors that include hundred of inputs, hospital utilization, mobility data, and current infection rates.
In such a mass, the bot will prove itself to be a good decision-maker as it will send the vaccines to those in utmost need. But, with AI, the developers need to understand the pattern to avoid bias.
7. AI-based chatbots
AI-infused chatbots are a great example of AI’s application in COVID vaccine rollout. The bots address the COVID 19 questions through the population’s existing voice, chat, or social media channels.
Tony Bates, the CEO of Genesys, says that their company has released COVOD-19 vaccine response, a digital solution that will enable the companies to use AI-enabled chatbots.
The bot will address the requests for information from more than 330 million people in states.
Final Words
AI has become an integral part of the digital industry and now the pharmaceutical industry as well. With the COVID 19 vaccine rollout, AI has proved to be the catalyst in time-saving and efficacy capabilities.
41 percent of the healthcare executives from the pharmaceutical industry have reported that AI is one such technology that has the most significant impact on them since the time vaccine has been in the market. It has empowered human healthcare professionals and helped them work faster and better.
It‘s the right time when the healthcare sector dealing with COVID 19 vaccine rollout shipment should cherish and adapt the benefits in COVID vaccine rollout and hire AI developers to leverage this technology’s power.
